SUPN compared with LGND: revenue, margins and what each company keeps, and the suppliers and customers both name

SUPNSupernus Pharmaceuticals, Inc.

Mkt capRevenueRevenue

LGNDLigand Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

SUPNSupernus Pharmaceuticals, Inc.

LGNDLigand Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SUPN 12

MCKMcKessoncustomer

CAHCardinal Healthcustomer

BIIBBiogencustomer

CNCCencoracustomer

8 more · SUPN chain ›

Shared 0

No shared counterparties.

Only LGND 28

MRKMerckcustomer

AMGNAmgencustomer

GILDGileadcustomer

JAZZJazz Pharmaceuticalscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

24 more · LGND chain ›

SUPNSupernus Pharmaceuticals, Inc.

26.15▼−2.21%· post 26.15

Mkt cap$3.1BRevenue$356MQ3 FY26Revenue$719MFY25

LGNDLigand Pharmaceuticals Inc

306.27▲+2.43%· post 308.00

ClosedNov 6 '26

Mkt cap$6.1BRevenue$79MQ3 FY26Revenue$268MFY25

Compare

ClosedNov 6 '26

SUPNSupernus Pharmaceuticals, Inc.

LGNDLigand Pharmaceuticals Inc

26.15▼−2.21%post 26.15

Price

306.27▲+2.43%post 308.00

$3.1B

Mkt cap

$6.1B

Q3 FY26$356M

Revenue

$79MQ3 FY26

FY25$719M

Revenue

$268MFY25

SUPN26.15▼−2.21%vsLGND306.27▲+2.43%ClosedNov 6 '26